.webp)
Poster sessions
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients with Metastatic (Stage IV) Breast Cancer
Time: 5:30 PM - 7:00 PM
Where: Henry B. Gonzalez Convention Center
Presenter: Frances Valdes, MD, University of Miami
Share your #BostonGene
experience and tag us online!
![]()
![]()
experience and tag us online!
.webp)
Accelerate drug development
.webp)
.webp)
.webp)
.webp)
Precision diagnostics in the clinic
.webp)
Publications
Visit Publications
Cancer Cell • May 14, 2024
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer
Article
.webp)
Cancer Cell • May 1, 2021
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
Article
Cancer Cell • August 1, 2022
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes
Article
Latest news
Visit news
WALTHAM, Mass • August 1, 2024
BostonGene Announces Partnership with Takeda to Evaluate Immunotherapies Using AI-Powered Molecular Profiling
Article
.webp)
WALTHAM, Mass • November 12, 2024
GlobalData Honors BostonGene with Five Awards in the 2024 Pharmaceutical Technology Excellence Awards
Article
Awards
